Statistics for Off-label use of bevacizumab in age-related macular degeneration: protocol for a systematic review and meta-analysis
Total visits
| views | |
|---|---|
| Off-label use of bevacizumab in age-related macular degeneration: protocol for a systematic review and meta-analysis | 80 |
Total visits per month
| views | |
|---|---|
| September 2024 | 2 |
| October 2024 | 0 |
| November 2024 | 4 |
| December 2024 | 4 |
| January 2025 | 1 |
| February 2025 | 0 |
| March 2025 | 0 |
File Visits
| views | |
|---|---|
| Off-label use of bevacizumab in age-related macular degeneration_protocol for a systematic review and meta-analysis.pdf(legacy) | 56 |
| Off-label use of bevacizumab in age-related macular degeneration_protocol for a systematic review and meta-analysis.pdf | 9 |
Top country views
| views | |
|---|---|
| Portugal | 26 |
| United States | 21 |
| China | 8 |
| Iran | 4 |
| France | 2 |
| South Korea | 2 |
| Argentina | 1 |
| Australia | 1 |
| Canada | 1 |
| Germany | 1 |
| Denmark | 1 |
| United Kingdom | 1 |
| Greece | 1 |
| Indonesia | 1 |
| India | 1 |
| Mongolia | 1 |
| Nigeria | 1 |
| Pakistan | 1 |
| Romania | 1 |
| Singapore | 1 |
| Ukraine | 1 |
| South Africa | 1 |